 Gritstone bio is developing targeted immunotherapies for infectious diseases and cancer by enhancing the bodys immune system to recognize and destroy unhealthy cells by targeting specific antigens. Gritstone has developed a self-amplifying mRNA COVID-19 vaccine, as well as an HIV candidate and several oncology programs. 